Julie Ann Mayer
Overview
Explore the profile of Julie Ann Mayer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
985
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sweed N, Hsiao H, Blouw B, Pircher T, Fisher D, Naluz K, et al.
Arch Pathol Lab Med
. 2024 May;
149(3):242-252.
PMID: 38797516
Context.—: Leptomeningeal disease (LMD) is a clinical sequela of central nervous system metastasis involving the cerebrospinal fluid (CSF), often seen in late-stage solid tumors. It has a grave prognosis without...
2.
Wooster M, McGuinness J, Fenn K, Singh V, Franks L, Lee S, et al.
Clin Breast Cancer
. 2021 Dec;
22(4):e457-e462.
PMID: 34920954
Introduction: Diagnosis of LM is limited by low sensitivity of cerebrospinal fluid (CSF) cytopathology. Detecting tumor cells in CSF (CSF-TCs) might be more sensitive. We evaluated if CNSide (CNSide), a...
3.
Pradeep S, Kim S, Wu S, Nishimura M, Chaluvally-Raghavan P, Miyake T, et al.
Cancer Cell
. 2014 Jul;
26(1):77-91.
PMID: 25026212
Ovarian cancer has a clear predilection for metastasis to the omentum, but the underlying mechanisms involved in ovarian cancer spread are not well understood. Here, we used a parabiosis model...
4.
Krishnamurthy S, Bischoff F, Mayer J, Wong K, Pham T, Kuerer H, et al.
Cancer Med
. 2013 May;
2(2):226-33.
PMID: 23634290
Human epidermal growth factor receptor 2 (HER2) gene amplification in circulating tumor cells (CTCs) and disseminated tumor cells (DTCs) might be useful for modifying Herceptin therapy in breast cancer. In...
5.
Wang C, Uray I, Mazumdar A, Mayer J, Brown P
Breast Cancer Res Treat
. 2012 Jan;
134(1):101-15.
PMID: 22212555
Estrogen signaling is a critical pathway that plays a key role in the pathogenesis of breast cancer. In a previous transcriptional profiling study, we identified a novel panel of estrogen-induced...
6.
Mayer J, Pham T, Wong K, Scoggin J, Sales E, Clarin T, et al.
Cancer Genet
. 2011 Dec;
204(11):589-95.
PMID: 22200084
Determination of HER2 status in breast cancer patients is considered standard practice for therapy selection. However, tumor biopsy in patients with recurrent and/or metastatic disease is not always feasible. Thus,...
7.
Pecot C, Bischoff F, Mayer J, Wong K, Pham T, Bottsford-Miller J, et al.
Cancer Discov
. 2011 Dec;
1(7):580-6.
PMID: 22180853
Unlabelled: Metastasis is a complex, multistep process that begins with the epithelial-mesenchymal transition (EMT). Circulating tumor cells (CTC) are believed to have undergone EMT and thus lack or express low...
8.
Wang C, Mayer J, Mazumdar A, Brown P
Breast Cancer Res Treat
. 2011 Sep;
133(2):487-500.
PMID: 21947652
The rearranged during transfection/papillary thyroid carcinoma (RET/PTC) tyrosine kinase is an oncogene implicated in the tumorigenesis of thyroid cancer. Recent studies by us and others have shown that RET/PTC kinase...
9.
Wang C, Mayer J, Mazumdar A, Fertuck K, Kim H, Brown M, et al.
Mol Endocrinol
. 2011 Aug;
25(9):1527-38.
PMID: 21835891
c-myc oncogene is implicated in tumorigenesis of many cancers, including breast cancer. Although c-myc is a well-known estrogen-induced gene, its promoter has no estrogen-response element, and the underlying mechanism by...
10.
Chen L, Mayer J, Krisko T, Speers C, Wang T, Hilsenbeck S, et al.
Cancer Res
. 2009 Nov;
69(23):8853-61.
PMID: 19920204
p38 kinases are members of the mitogen-activated protein kinase family that transduce signals from various environmental stresses, growth factors, and steroid hormones. p38 is highly expressed in aggressive and invasive...